chr11-5453648-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004754.3(OR51I2):āc.160A>Gā(p.Ser54Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000818 in 1,613,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004754.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR51I2 | NM_001004754.3 | c.160A>G | p.Ser54Gly | missense_variant | 2/2 | ENST00000641930.1 | |
OR51B5 | NM_001005567.3 | c.-360+51921T>C | intron_variant | ||||
OR51B5 | NR_038321.2 | n.84+51921T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR51I2 | ENST00000641930.1 | c.160A>G | p.Ser54Gly | missense_variant | 2/2 | NM_001004754.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000679 AC: 17AN: 250376Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135242
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461234Hom.: 0 Cov.: 45 AF XY: 0.0000509 AC XY: 37AN XY: 726876
GnomAD4 genome AF: 0.000335 AC: 51AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2021 | The c.160A>G (p.S54G) alteration is located in exon 1 (coding exon 1) of the OR51I2 gene. This alteration results from a A to G substitution at nucleotide position 160, causing the serine (S) at amino acid position 54 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at